Group 4F: HER2+ & Triple Negative Breast Cancer; Brain Metastasis; Clinical Trials; Immunotherapy

Poster #TPS1112: Phase IIa study of αDC1 vaccines targeting HER2/HER3 combined with pembrolizumab in patients with asymptomatic brain metastasis from triple negative breast cancer or HER2+ breast cancer

Poster #TPS1113: Phase I study of adoptive T cell therapy following HER2-pulsed dendritic cell vaccine and pepinemab/trastuzumab in patients with metastatic HER2-positive breast cancer (MBC)